Determination of efficacy and toxicity of diclofenac microemulsion formulation for musculoskeletal pain: an observational study.
Hoan Linh BanhAndrew CavePublished in: BMC research notes (2020)
Thirteen consecutive patients with musculoskeletal pain consented to participate. Two patients were lost to follow up. Two of the 11 patients reported minimal improvement, while nine patients reported minimum 50% reduction. No adverse effects were reported. Diclofenac 2% in microemulsion foam is effective in the treatment of mild to moderate musculoskeletal pain and well tolerated.